AI filing briefs · archive

8-K filings in October 2026, explained

3,560 material Form 8-K filings that 2,489 companies we cover made with the SEC in October 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). 2,508 of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).

Clear

13 of 3,560 briefs match

newest first · times in ET
CHRDChord Energy Corp Oct 19, 5:27 PM ET

Chord Energy CEO Daniel Brown resigns; Michael Lou named CEO as Q3 volumes beat guidance

Mixed leadership 2.025.027.01

Chord Energy said CEO Daniel Brown resigned effective October 19, 2026, and named Michael Lou, its former Chief Strategy and Chief Commercial Officer, as President and CEO and a director. In preliminary third-quarter results, the company said volumes exceeded the high end of its August 2026 guidance and adjusted free cash flow was above expectations, but the filing gives no revenue or net income figures and the financial statements are not yet final.

  • Daniel Brown resigned as President and CEO and as a director effective October 19, 2026, to pursue another professional opportunity, and will receive no severance.
  • Michael Lou, age 52, was appointed President and CEO effective October 19, 2026, and will not serve on any Board committees for now.
  • Chord repurchased $205 million of shares in 3Q26 at an average price of $135.74, and another $44.3 million in 4Q26 to date at $142.32.
  • At September 30, 2026, cash and cash equivalents were $804.7 million and total debt was $1,482.2 million; a non-operated Marcellus divestiture has $550 million in total gross consideration.
Read the filing on SEC.gov ↗
VENUVenu Holding Corp Oct 19, 5:20 PM ET

Venu Holding cuts Debenture principal to $12.5 million; President William Hodgson departs

Mixed leadership Written later 5.028.01

Venu Holding Corporation said its President, William Hodgson, will leave the role effective immediately, with his employment ending December 1, 2026, and no successor named. The company also applied a $12.5 million holdback to reduce its $25 million convertible debenture principal and halve the warrant shares tied to it, which the company said reduces debt service and potential dilution.

  • William Hodgson ceased to serve as President effective October 13, 2026 (agreed date); employment continues until December 1, 2026, with severance expected over a 90-day period
  • Debenture principal reduced from $25,000,000 to $12,500,000 via holdback applied as of September 30, 2026; each installment cut from $5,000,000 to $2,500,000
  • Investor Warrants reduced from 1,000,000 to 500,000 shares; Placement Agent Warrants reduced from 200,000 to 100,000 shares
  • Aramark completed its additional Series B Preferred Stock investment of $5,010,000 on October 15, 2026; first debenture installment of $2,875,000 paid October 14, 2026
Read the filing on SEC.gov ↗
VVOSVivos Therapeutics, Inc. Oct 19, 4:49 PM ET

Vivos Therapeutics closes SOD Sciences stake and 50% test interest for preferred stock

Mixed m&a Written later 1.012.013.023.035.037.018.01

Vivos Therapeutics closed on October 16, 2026 its acquisition of an 11% fully diluted stake in SOD Sciences and a 50% co-ownership interest in SOD's pseudohypoxia early-warning test, paying with 12,000 shares of newly created Series C Convertible Preferred Stock and no cash. The preferred converts at $0.15 per share into up to 80,000,000 common shares, which could dilute existing holders, and the company expects the deal to raise stockholders' equity by more than $10 million, which it says may restore compliance with a Nasdaq minimum.

  • Closed October 16, 2026: 3,057,879 SOD common shares (at least 11% fully diluted) plus a 50% interest in the test and related IP, for 12,000 Series C Preferred with a $12,000,000 aggregate stated value; no cash paid.
  • Series C converts at $0.15 per share into up to 80,000,000 common shares; until stockholder approval, conversions are capped at 6,718,517 shares, against 33,609,393 common shares outstanding before the signing.
  • Vivos expects stockholders' equity to rise by more than $10 million, citing $10,380,000 of expected additional equity, and believes this restores compliance with Nasdaq's $2.5 million stockholders' equity requirement, subject to Nasdaq revi
  • Commercial benefits depend on definitive agreements with AHA, which is in bankruptcy proceedings, and Cleveland Clinic Weston, neither of which had been executed as of the filing.
Read the filing on SEC.gov ↗
PVLPermianville Royalty Trust Oct 19, 4:33 PM ET

Permianville Royalty Trust declares $0.015 monthly distribution payable Nov. 13, 2026

Mixed shareholder Written later 2.02

Permianville Royalty Trust announced a cash distribution of $0.015 per unit, payable November 13, 2026, to unitholders of record on October 30, 2026. Oil receipts fell $0.8 million on a lower average oil price, while natural gas receipts rose $1.2 million, and the sponsor withheld an additional $0.3 million for a development reserve that now totals $2.0 million.

  • Distribution of $0.015 per unit; record date October 30, 2026; payable November 13, 2026.
  • Oil receipts totaled $3.1 million at $81.06 per barrel, down $0.8 million from the prior month, when the average price was $92.96 per barrel.
  • Natural gas receipts totaled $2.4 million at $3.05 per Mcf, up $1.2 million, helped in part by three newly drilled Haynesville wells.
  • COERT Holdings 1 LLC withheld an additional $0.3 million from current net profits, bringing its development reserve to $2.0 million.
Read the filing on SEC.gov ↗
RLIRLI CORP Oct 19, 4:20 PM ET

RLI Q3 net earnings fell 35% to $81.0 million; operating EPS rose to $0.86

Mixed earnings 2.02

RLI Corp. reported third quarter 2026 net earnings of $81.0 million ($0.88 per diluted share), down 35.0% from $124.6 million ($1.35 per share) a year earlier. Operating earnings rose 4.6% to $79.3 million ($0.86 per share), but underwriting income fell to $58.8 million on a combined ratio of 86.2, compared with $60.5 million on 85.1 in the prior-year quarter.

  • Q3 2026 net earnings $81.0 million ($0.88 per share) vs. $124.6 million ($1.35) in Q3 2025
  • Q3 2026 operating earnings $79.3 million ($0.86 per share) vs. $75.8 million ($0.82) in Q3 2025
  • Underwriting income $58.8 million on an 86.2 combined ratio vs. $60.5 million on 85.1; gross premiums written rose 2% and net investment income rose 13%
  • Repurchased 103,573 shares for $6.3 million in Q3; $231.7 million of repurchase capacity remained as of September 30, 2026
Read the filing on SEC.gov ↗
WRBBERKLEY W R CORP Oct 19, 4:12 PM ET

W. R. Berkley Q3 net income falls to $446 million; operating income rises 6.4%

Mixed earnings 2.02

W. R. Berkley reported third quarter 2026 results on October 19, 2026. GAAP net income to common stockholders fell to $446.0 million, or $1.14 per diluted share, from $511.0 million, or $1.28, a year earlier, while operating income, a non-GAAP measure, rose to $456.5 million, or $1.17 per share. The filing gives no new full-year guidance, so shareholders see mixed signals on reported versus underlying profit.

  • Net income to common stockholders was $446.0 million, or $1.14 per diluted share, versus $511.0 million, or $1.28, in the third quarter of 2025.
  • Operating income rose to $456.5 million, or $1.17 per diluted share, from $440.2 million, or $1.10, a year earlier.
  • Pre-tax underwriting income for the Insurance segment grew 10.6% to $237.7 million, and the reported combined ratio was 90.8%.
  • Net investment income rose to $383.5 million from $351.2 million; the company repurchased $21.1 million of shares in the quarter and returned $728.6 million to shareholders year to date.
Read the filing on SEC.gov ↗
GTMZoomInfo Technologies Inc. Oct 19, 4:05 PM ET

ZoomInfo agrees to pay $44 million to settle securities class action lawsuit

Mixed legal/regulatory 1.01

ZoomInfo signed a memorandum of understanding on October 16, 2026, setting terms for a proposed settlement of a securities class action filed on September 4, 2024. The settlement provides for a $44 million payment to the class, a portion of which is expected to be covered by remaining insurance funds, and requires approval by the Washington District Court. The settlement would not resolve related shareholder derivative lawsuits, a related opt-out action, or a separate class action filed on June 25, 2026.

  • $44 million payment to the putative class, with a portion expected to be covered by remaining insurance funds
  • Memorandum of understanding executed October 16, 2026; subject to preliminary and final approval by the Washington District Court
  • Settlement would not resolve shareholder derivative suits, an opt-out direct action, or the class action filed June 25, 2026
Read the filing on SEC.gov ↗
SKYASkyAI, Inc. Oct 19, 9:14 AM ET

SkyAI starts tender offer for up to 95% of shares, warrants at $3.00 each

Mixed shareholder Written later 8.01

SkyAI commenced on October 16, 2026, a cash tender offer to buy up to 95% of each class of its common stock and warrants at $3.00 per share or warrant, with the offer set to expire on October 29, 2026 unless extended. If fully subscribed, the purchase would cost about $201.3 million, paid from cash on hand of about $223.8 million as of October 16, 2026. For shareholders, the offer gives an option to sell for cash at a price the company says is about 0.95 times its net asset value, but it would use most of the company's cash.

  • Offer expires at one minute after 11:59 p.m. New York City time on October 29, 2026, unless extended or terminated early
  • Seeks up to 48,311,489 common shares, 4,880,734 cash pre-funded warrants, 9,939,850 cryptocurrency pre-funded warrants and 3,955,293 strategic warrants
  • Company held about $223.8 million in cash as of October 16, 2026, and has sold all of its SOL; the offer has no financing condition
  • Each class is conditioned on at least 50% of that class being tendered; the Board approved the offer but makes no recommendation to holders
Read the filing on SEC.gov ↗
DAIODATA I/O CORP Oct 19, 9:00 AM ET

Data I/O agrees to acquire V-TEK, A&J Programming for about $23 million

Mixed m&a Written later 7.01

On October 19, 2026, Data I/O signed a definitive agreement to acquire V-TEK, Inc., a Mankato, MN maker of semiconductor handling and packaging solutions, and A&J Programming, Inc., a San Jose, CA device programming service provider. The total purchase price is about $23 million, paid in cash and Company common stock, and the company said the acquisition is expected to close this week. The same day, it announced a proposed private placement of about $13.25 million that includes convertible debentures and common shares, with a shareholder vote needed for issuances above 19.9% of shares outstanding.

  • Total purchase price of about $23 million, including about $3 million in Data I/O common stock (about 1.12 million shares)
  • Proposed private placement of about $13.25 million, with $7.25 million in debentures converting at $2.68 per share
  • Special shareholder meeting expected within 120 days of closing to approve issuances above 19.9% of shares outstanding
  • Lead investor from the June 2026 private placement committed an additional $4.0 million
Read the filing on SEC.gov ↗

Cardinal Infrastructure Group amends $357.5 million Hughes Brothers deal

Mixed m&a Written later 1.013.027.01

On October 18, 2026, Cardinal Infrastructure Group amended its agreement to acquire Hughes Brothers Construction Inc. The purchase price remains $357.5 million, but consideration shifts to 60% cash and 40% Cardinal Class A common stock, up from 50% of each, and the earnout is revised to a maximum of $162.5 million. For shareholders, the deal adds new shares and debt-funded cash, and the company expects closing in the fourth quarter of 2026.

  • Purchase price stays at $357.5 million; cash portion is $214.5 million, versus 50% cash under the original terms.
  • Stock consideration is 5,255,420 shares, based on a $27.21 Signing Date VWAP, with a 180-day lock-up for the sellers.
  • Earnout of up to $162.5 million depends on Hughes Brothers adjusted EBITDA for the twelve months ending June 30, 2027; the maximum would add up to 2,388,827 shares.
  • Closing is expected in the fourth quarter of 2026, subject to HSR clearance and other conditions; Cardinal says the deal is immediately accretive to adjusted EBITDA per share.
Read the filing on SEC.gov ↗
OSTXOS Therapies Inc Oct 19, 8:47 AM ET

OS Therapies raises $7.2 million from warrant exercises at a reduced price

Mixed financing Written later 1.013.028.01

OS Therapies said on October 15, 2026 that seven holders exercised or pre-funded 5,517,253 existing warrants at a reduced price of $1.30 per share, bringing in about $7.2 million in gross proceeds before fees. In exchange, the company issued new five-year warrants for the same number of shares at $1.40, and the company says the offer could bring about $12.3 million in total if all existing warrants are exercised. Because the new warrants add potential share issuance, the deal provides near-term capital but also raises potential dilution for existing shareholders.

  • Initial closing on October 15, 2026: seven holders exercised or pre-funded warrants for 5,517,253 shares at $1.30 per share, for about $7.2 million gross.
  • New warrants issued for 5,517,253 shares at $1.40 per share, expiring five years from issuance; if all existing warrants are exercised, up to 9,448,060 new warrant shares could be issued.
  • Company agreed to pay a solicitation agent a 7.0% cash fee on gross proceeds plus a $25,000 expense allowance; the offer expires at 11:59 p.m. Eastern on October 30, 2026.
  • Company plans to file a resale registration statement by November 30, 2026, and says proceeds will fund Herlystic clinical, regulatory and commercial preparation work.
Read the filing on SEC.gov ↗

Eos Energy Q3 revenue of $82 million to $83 million; gross margin remains negative

Mixed earnings Written later 2.027.018.01

Eos Energy said preliminary third-quarter 2026 revenue of $82 million to $83 million rose about 169% to 172% from a year earlier, while gross margin remained a loss of 53% to 55%. The company now expects full-year 2026 revenue in the lower half of its $300 million to $350 million range, and the figures are unaudited and may change before full results on November 5, 2026.

  • Preliminary Q3 2026 revenue of $82 million to $83 million, up about 19% to 21% sequentially and 169% to 172% year over year
  • GAAP gross margin of (55)% to (53)%, an improvement of about 16 to 18 percentage points versus Q2 2026
  • Total cash including restricted cash was about $344 million on September 30, 2026, down from $364 million on June 30, 2026; backlog was about $765 million
  • Full-year 2026 revenue now expected in the lower half of the $300 million to $350 million range; full Q3 results due November 5, 2026
Read the filing on SEC.gov ↗
TMSTeamshares Inc Oct 19, 8:16 AM ET

Teamshares refinances $150 million credit facility with $130 million term loan

Mixed financing Written later 1.011.022.033.037.01

On October 16, 2026, Teamshares Continuity Holdings LLC, a subsidiary of Teamshares Inc, entered into a $130.0 million senior secured term loan and used it, with cash on hand, to repay in full the $150.0 million Existing Credit Agreement, with a payoff of about $152.8 million including accrued interest. The new loan carries a rate of one-month Term SOFR (3.00% floor) plus 9.50%, down from 11.00% on the old facility, but while it is outstanding the Company may not pay dividends or repurchase its equity without the agent's consent.

  • New $130.0 million term loan matures on the fourth anniversary of the October 16, 2026 closing date, with quarterly principal payments starting December 31, 2026
  • Interest rate is one-month Term SOFR (3.00% floor) plus 9.50%, versus Term SOFR (3.00% floor) plus 11.00% on the repaid facility
  • Company expects annual interest expense to decrease by approximately $5 million at current SOFR levels, per the press release
  • Credit agreement restricts dividends and equity repurchases without Agent consent, limiting shareholder payouts while the loan is outstanding
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.